NeoGenomics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
NeoGenomics, Inc. (NEO) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $17.09 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-17
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $17.09M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18.33M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $21.28M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $21.23M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $17.09M 10-K · filed 2026-02-17 |
| 2024-12-31 | $18.33M 10-K · filed 2025-02-18 |
| 2023-12-31 | $21.28M 10-K · filed 2024-02-20 |
| 2022-12-31 | $21.23M 10-K · filed 2023-02-24 |
| 2021-12-31 | $23.61M 10-K · filed 2022-02-25 |
| 2021-09-30 | $24.10M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $14.20M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $13.94M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $14.06M 10-K · filed 2021-02-25 |
| 2020-09-30 | $14.59M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $15.31M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $15.18M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $8.87M 10-K · filed 2020-02-28 |
| 2019-09-30 | $9.25M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $9.54M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $7.94M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |